GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
62.32
-4.53 (-6.78%)
At close: May 1, 2025, 4:00 PM
62.73
+0.41 (0.66%)
After-hours: May 1, 2025, 5:55 PM EDT

Company Description

GeneDx Holdings Corp., a genomics company, provides genetic testing services.

It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

The company is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.
GeneDx Holdings logo
Country United States
Founded 2017
Industry Diagnostics & Research
Sector Healthcare
Employees 1,000
CEO Katherine Stueland

Contact Details

Address:
North Tower, 6th Floor
Stamford, Connecticut 06902
United States
Phone 888 729 1206
Website genedx.com

Stock Details

Ticker Symbol WGS
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001818331
CUSIP Number 81663L200
ISIN Number US81663L2007
Employer ID 85-1966622
SIC Code 8000

Key Executives

Name Position
Katherine A. Stueland President, Chief Executive Officer and Director
Kevin Feeley CPA Chief Financial Officer
Dr. Bryan M. Dechairo Ph.D. Chief Operating Officer
Eric Olivares Ph.D. Chief Product and Technology Officer
Heidi C. Chen J.D. Chief Legal Officer
Jami Biliboaca Head of People Strategy
Paul Kruszka FACMG, M.D., M.P.H. Chief Medical Officer
Melanie Duquette Chief Growth Officer
Sabrina Dunbar Chief of Staff

Latest SEC Filings

Date Type Title
Apr 30, 2025 ARS Filing
Apr 30, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2025 DEF 14A Other definitive proxy statements
Apr 30, 2025 10-Q Quarterly Report
Apr 30, 2025 8-K Current Report
Apr 29, 2025 144 Filing
Apr 29, 2025 144 Filing
Apr 16, 2025 8-K Current Report
Apr 14, 2025 144 Filing
Apr 9, 2025 144 Filing